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Abstract  
Background: Hepatitis viruses are one of the serious medical problems and Hepatitis B is one of the chief 
transferable disease via blood and its products. Nowadays, 11 genotypes of hepatitis B have known over the 
world by the genome sequencing. Hepatitis B viruses have special geographical distribution. The clinical 
importance of hepatitis B viruses and its relation with the mutations has recognized. The purpose of this study 
was to check the presence and prevalence of Hepatitis B virus genotypes among the referrals attended to the 
medical diagnostic laboratories in Kerman province. 
Materials and Methods: In this cross-sectional study, twenty-one specimens were collected from blood 
samples available in the medical diagnostic laboratories of Kerman province during one year. After DNA 
extraction, PCR was carried on by specific primers, then they were sequenced. The obtained sequenced were 
compared with sequences in the NCBI gene bank and blasted for identification of their genotypes. 
Results: Seven samples from twenty one samples (33.3%) had D genotype, 13 samples from 21 (62%) had 
D3 subgenotype and 1 sample from 21 (4.7%) had D4 subgenotype.  
Conclusion: The prevalence of these genotypes in the Kermanian patients that recognized in this study can 
help to provide diagnostic kits for hepatitis B virus. 
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Introduction 
Chronic hepatitis B is one of the biggest medical 
problems. It is reported annually more than 400 
million cases in the world, 15-40% of these patients 
eventually develop liver cirrhosis, hepatic failure, 
and hepatocellular carcinoma
1,2
. Hepatitis B virus is a 
member of the Hepadenaviridea family. This small 
double strain DNA virus has four overlapping genes, 
including nucleocapsid, envelope, polymerase with 
transcriptase activity and X proteins
3
.  
Sometimes Chronic hepatitis B may overlap with 
several viral diseases. Chronic hepatitis B may be 
associated with the infection of important viruses like 
HIV, HTLV, HCV, HDV, HAV and HEV. In recent 
years, debate on chronic HBe-Ag negative hepatitis 
has been greatly increased. These patients are in two 
groups: patients with negative HBe-Ab and patients 
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with positive HBe-Ab
1
.  
Hepatitis B virus is transmitted through blood and 
other body fluids, including semen and saliva. The 
chance of this virus transmission is 100 times higher 
than the HIV virus and unlike the HIV; it can survive 
out of the body as well as in the dried blood for a 
couple of weeks
4
. This disease is often transmitted 
through embryonic or early childhood in Southeast of 
Asia, China, and Africa
5
. This is the reason of the 
high prevalence of this disease (5-20%) in these 
areas
6
. 
Lamivudine is a well-known drug used in chronic 
hepatitis B to stop the proliferation of B virus and 
improve liver lesions in 20-40% of European adult 
patients
6
. Lamivudine is an oral drug that is well 
tolerated and it is effective in HBe-Ag positive 
hepatitis and in the type of HBe-Ab positive. It acts 
as a nucleoside analog and acts as a DNA closure 
agent
7,8
. Mutation is possible in various sections of 
HBV genome. The most common mutation happens 
in precore region (G1896A), and in this case, HBe-
Ag cannot be synthesized
9
. So far 11 genotypes A to 
J have been recognized by sequencing the complete 
genome of the hepatitis B virus which is isolated 
from patients over the world
10,11
. Hepatitis B virus 
genotypes have a specific geographic distribution and 
clinical importance of genotypes has been recently 
discussed in their pathogenesis
10,11
. The clinical 
pathology and the result of chronic hepatitis B are 
different in different genotypes
12
. HBV genotypes 
indicate their transmission as well as their geographic 
dispersion and in migrant populations show the 
geographical location of their migration
13
. It is 
reported that the type of genotypes are important in 
their clinical outcomes
14
. Some researchers believe 
that D genotype responds better to treatment of 
Lamivudine than genotype A
15
. In this study, the 
genotypes of Hepatitis B virus in patients from the 
Kerman province studied by molecular and 
sequencing methods. 
Methods 
Sample collection and DNA extraction: This study 
was a cross-sectional descriptive. Twenty-one 
specimens were collected from blood samples 
available in the medical diagnostic laboratories of 
Kerman province during one year (2016-2017). 
Including criteria was molecular and serologic positive 
samples. Samples were stored at -20°C before DNA 
extraction. For DNA extraction, the blood samples 
were centrifuged with 13000 RPM for 5 minutes then 
200 µl of supernatant were used for DNA extraction. 
DNA extraction was performed using the Roch's High-
pure viral nucleic acid kit. Then the DNA purity and 
concentration were determined by the NanoDrop and 
finally the appropriate samples were selected. 
Polymerase chain reaction (PCR): To carry out 
PCR, the sequence of HBV primers was determined 
and synthesized in the SinaClon company in Iran 
(Table 1). Reaction of PCR was carried out using Taq 
DNA polymerase master mix (Ampliqon). The 
thermocycler was programmed at 95°C for 5 mins, 
followed by 95°C for 30s, 57°C for 30s, 72°C for 1 
min and an additional 72°C for 5 mins. The PCR 
product was detected by gel electrophoresis on a 2% 
agarose gel. Samples with 541bps single band were 
sent to the Pouya Gostar Gene company in Iran for 
sequencing. Sequences were blasted with the genome 
of different genotypes of HBV virus in the NCBI gene 
bank and then the genotypes of the samples were 
determined. 
Results 
Result of PCR showed in Figure 1. All the 21 samples 
showed 541bps specific bands and then they were 
sequenced. Sequences were blasted in the NCBI gene 
bank and the genotypes of the samples were 
determined (Table 2). Based on the maximum 
nucleotide matching, these isolated sequences were 
similar (98-99%) to isolates in Belarus (named mn D-
N15), Indonesia (named TRF68226) and Martinique 
(named mart B47, mart B58, and mart B36). Isolates 
in this study were assorted in D genotype, D3 and D4 
subgenotpes. 
The results of this study showed 7 samples of 21 
(33.3%) had nucleotide similarity to D genotype 
isolates (mnD-N15 isolate from Belarus and 
TRFO8286 isolate from Indonesia), 13 samples of 21 
(62%) were similar to D3 subgenotype isolates (mart 
B47 and mart B58 isolates from Martinique) and 1 of 
21 (4.7%) were similar to D4 isolate (mart B36 isolate 
from Martinique). 
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Discussion 
Chronic liver inflammation changes to liver fibrosis 
enhances the risk of hepatocellular carcinoma
16
. 
Therefore, accurate diagnosis of this disease is 
important in the early stages. Different studies results 
indicated the high accuracy of molecular methods in 
detecting of HBV in patients. In many studies, along 
with serological methods, molecular methods are 
used for confirmation
17, 18
 and some studies 
confirmed the accuracy of molecular methods
17, 18, 19
. 
Molecular methods have also been used to identify 
and determine the genotypes of this virus in various 
studies
20, 21
. In this study, due to the precision of 
molecular methods, PCR technique was used to 
identify patients.  
Several studies are proving the prevalence of one or 
more specific genotype among people in a 
population. The genotype infecting people in Spain 
and Sweden was reported genotype D, genotype H 
was in California and Mexico
22
. In other studies, 121 
patients in France and the United States were 
investigated and genotypes A and G were the 
dominant genotypes of the disease
23
. In Bangladesh, 
HBV genotyping studies on 39 patients with hepatitis 
B indicated the genotype C is dominant compared to D 
and A genotypes in this region
10
. A South Korean 
study showed that all of 6 people with hepatocellular 
carcinoma that were investigated, had genotype C of 
HBV
24
. HBV Genotype determining studies in Iran 
indicated the prevalence of genotype D in Golestan 
provinces
19
, Yazd
25
, Esfahan
26
 and Mashhad
27
. In 
addition, a study on blood donors in Kerman province 
confirms the prevalence of genotype D in donors
26
. 
Also, based on a study performed on 23 patients in 
Shahrekord city, D and C genotypes were found
28
. In 
Tehran, D genotype and D1 subgenotype were 
reported
29
. The results of most studies in Iran indicated 
that D genotype is the most dominant genotype in 
Iran
30, 31
. 
In this study, HBV genotypes were determined by the 
NCBI genotyping tools. This study showed that D 
genotype is prevalent genotype in Kerman province. 
The present study results has confirmed the result of 
Sharifi et al, study
26
. In addition, some Iranian studies 
showed the high prevalence of D genotypes of HBV in 
different regions of Iran, and these data confirm the 
results obtained in this study. In the neighboring 
countries such as Turkey, Pakistan, Afghanistan, and 
Russia, the most common genotype has also been 
reported D. Also in other countries like India, Saudi 
Arabia and, Egypt genotype D were reported
19, 21, 31
. 
Thus, the most common genotype reported in the 
Eastern Mediterranean region is the genotype D that is 
consistent with the present study.
 
Recent studies in Iran has shown the similarity of 
isolates of Iran with isolates from Turkey, Saudi 
Arabia, Lithuania, Element, France, Kazakhstan, and 
Belarus
26
. In the present study, HBV isolates show 
nucleotide similarity to the HBV isolates of Belarus, 
Indonesia, and Martinique. 
Conclusion 
Different HBV genotypes are varied in pathogenicity 
and response to treatment so HBV genotypes 
investigation make facilitate severity of disease, 
complications, response to treatment, vaccine response 
studies, purchase of diagnostic kits, immunological 
and genetic diagnosis, and the completion and 
improvement of screening program in Iran. The 
analysis of DNA extracted from HBV patients in 
Kerman province showed that the isolates of this study 
 
 
Figure 1. Specific PCR from HBV. The 5µl PCR product was 
loaded and 541bp band was seen. Columns 1 to 3 are positive 
samples, Column C-: negative control, Column C+: positive 
control, Column L: 100bp ladder. 
 
 
Table 1: HBV specific primers for PCR
27
. 
5'-CGGTAAAAAGGGACTCAAGAT-3 Forward 
5'-GTGGTGGACTTCTCTCAATTTTC-3' Reverse 
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have D genotype and D3, D4 subgenotypes. These 
results can also be used to provide quality control 
panels for evaluating the diagnostic methods for the 
virus. 
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